green_bg_gradient
/
Qelbree Logo

Sitemap

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

QelbreeTM (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in children ages 6 to 17.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE
Qelbree may increase suicidal thoughts and actions, especially within the first few months of treatment [read more] or when the dose is changed. Tell your child’s doctor if they have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your child’s moods, behaviors, thoughts and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE
Qelbree may increase suicidal thoughts and actions, especially within the first few months of treatment or when the dose is changed. [read more] Tell your child’s doctor if they have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your child’s moods, behaviors, thoughts and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

Your child should not take Qelbree if they:
Take a medicine for depression called monoamine oxidase inhibitor (MAOI), or stopped taking an MAOI in the last 14 days. Also, your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your child’s doctor if they show any signs of mania.

Do not let your teen drive or operate heavy machinery until you know how Qelbree will affect them. Qelbree may cause your teen to feel sleepy or tired.

The most common side effects of Qelbree include sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability. These are not all the possible side effects of Qelbree.

You may report negative side effects to the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.

Please see Medication Guide including Boxed Warning.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

QelbreeTM (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in children ages 6 to 17.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE
Qelbree may increase suicidal thoughts and actions, especially within the first few months of treatment [read more] or when the dose is changed. Tell your child’s doctor if they have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your child’s moods, behaviors, thoughts and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE
Qelbree may increase suicidal thoughts and actions, especially within the first few months of treatment or when the dose is changed. [read more] Tell your child’s doctor if they have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your child’s moods, behaviors, thoughts and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

Your child should not take Qelbree if they:
Take a medicine for depression called monoamine oxidase inhibitor (MAOI), or stopped taking an MAOI in the last 14 days. Also, your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your child’s doctor if they show any signs of mania.

Do not let your teen drive or operate heavy machinery until you know how Qelbree will affect them. Qelbree may cause your teen to feel sleepy or tired.

The most common side effects of Qelbree include sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability. These are not all the possible side effects of Qelbree.

You may report negative side effects to the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.

Please see Medication Guide including Boxed Warning.